Approval · Notice of Compliance 15198 · 2014
JUXTAPID: Notice of Compliance 15198
Issued February 4, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15198
- Date
- February 4, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Microsomal triglyceride transfer protein inhibitor
Products in this notice
Medicinal ingredients
- LOMITAPIDE MESYLATE 5 MG per CAP
- LOMITAPIDE MESYLATE 10 MG per CAP
- LOMITAPIDE MESYLATE 20 MG per CAP